FilingReader Intelligence

Shionogi amends Torii tender offer amid patent lawsuit developments

June 4, 2025 at 12:01 PM UTC•By FilingReader AI

Shionogi & Co., Ltd. (TSE:4507) has announced an amendment to its ongoing tender offer for shares of TORII Pharmaceutical Co., Ltd. (TSE:4551), initially launched on May 8, 2025. The amendment, filed with the Kanto Local Finance Bureau, addresses recent developments stemming from a patent infringement lawsuit announced by Toray Industries on May 27, 2025, concerning TORII's oral antipruritus medication REMITCH®.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

(Amendment) Notice of Amendment to “Notice of Tender Offer for Shares of TORII” Due to Submission of Amendment to Tender Offer StatementJune 4, 2025 at 06:30 AM UTC

Supplementary Source Documents

(Amendment) Notice of Amendment to "Notice Concerning Commencement of Tender Offer for Shares of Torii Pharmaceutical Co., Ltd." in Accordance with Submission of Amended Tender Offer StatementJune 4, 2025 at 06:30 AM UTC

Shionogi &

TSE:4507•Tokyo Stock Exchange

RSS feed for Shionogi &

News Alerts

Get instant email alerts when Shionogi & publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →